by Andrew Moran | Jan 7, 2024 | Articles, Business News, Good Reads, Opinion
President Joe Biden and his administration have repeatedly declared victory in the war on Big Pharma. Under the Inflation Reduction Act, Medicare can directly negotiate lower drug prices for about a dozen pharmaceuticals, such as Januvia (diabetes), Imbruvica (blood...
by James Fite | Dec 29, 2021 | Articles, Biden Administration, Good Reads
Cough, sniffle, sneeze. Is this just another cold – or the dreaded COVID-19? It’s time to spin that swab and find out, so you grab $25 or so and head to your friendly neighborhood pharmacy only to find the shelves devoid of any test kits. You could order on Amazon –...
by Andrew Moran | Aug 2, 2020 | Articles, Business News, Columns, Healthcare, Politics, Social Issues
President Donald Trump and his administration recently announced that Kodak would be transformed into a pharmaceutical producer under the Defense Production Act (DPA). The president confirmed that Kodak would receive a $765 million loan to establish Kodak...
by Andrew Moran | Feb 13, 2019 | Articles, Business News, Culture Rot, Economic Affairs News, Healthcare, Politics
The obligatory outrage after reports that a company has raised the price of a lifesaving drug by 300% has become a tired trope of modern-day politics. Every time one of these stories goes viral, both Republicans and Democrats showcase their disgust, request federal...
by Andrew Moran | May 16, 2018 | Politics
Despite the number of lives they save and the amount of pain they alleviate, drug makers are typically the target of scorn, derision, and resentment. If there is one issue that can usually garner bipartisan outrage it is drug prices. From Martin Shkreli raising the...